Tumor-Associated Microbiome: Where Do We Stand?
Authors:
Open Access
- 1 February 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3) , 1446
Abstract
The study of the human microbiome in oncology is a growing and rapidly evolving field. In the past few years, there has been an exponential increase in the number of studies investigating associations of microbiome and cancer, from oncogenesis and cancer progression to resistance or sensitivity to specific anticancer therapies. The gut microbiome is now known to play a significant role in antitumor immune responses and in predicting the efficacy of immune-checkpoint inhibitors in cancer patients. Beyond the gut, the tumor-associated microbiome—microbe communities located either in the tumor or within its body compartment—seems to interact with the local microenvironment and the tumor immune contexture, ultimately impacting cancer progression and treatment outcome. However, pre-clinical research focusing on causality and mechanistic pathways as well as proof-of-concept studies are still needed to fully understand the potential clinical utility of microbiome in cancer patients. Moreover, there is a need for the standardization of methodology and the implementation of quality control across microbiome studies to allow for a better interpretation and greater comparability of the results reported between them. This review summarizes the accumulating evidence in the field and discusses the current and upcoming challenges of microbiome studies.Keywords
This publication has 200 references indexed in Scilit:
- Computational meta'omics for microbial community studiesMolecular Systems Biology, 2013
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− miceNature, 2012
- Systems-level analysis of microbial community organization through combinatorial labeling and spectral imagingProceedings of the National Academy of Sciences, 2011
- Perspective: Alpha-Bugs, Their Microbial Partners, and the Link to Colon CancerThe Journal of Infectious Diseases, 2011
- Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiotaProceedings of the National Academy of Sciences, 2010
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- The Search for Infectious Causes of Human Cancers: Where and Why (Nobel Lecture)Angewandte Chemie International Edition, 2009
- Commensal DNA Limits Regulatory T Cell Conversion and Is a Natural Adjuvant of Intestinal Immune ResponsesImmunity, 2008
- A microbial symbiosis factor prevents intestinal inflammatory diseaseNature, 2008
- Helicobacter pylori and gastrointestinal tract adenocarcinomasNature Reviews Cancer, 2002